Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines

被引:4
|
作者
den Heijer, Jonas M. [1 ,2 ]
Heuberger, Jules A. A. C. [1 ,2 ]
Hijma, Hemme [1 ,2 ]
Kruithof, Annelieke C. [1 ,2 ]
van Smeden, Jeroen [1 ,2 ]
Groeneveld, Geert Jan [1 ,2 ]
Burggraaf, Jacobus [1 ,2 ]
Cohen, Adam [1 ,2 ]
机构
[1] Ctr Human Drug Res, Clin Pharmacol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Clin Pharmacol, Leiden, Netherlands
关键词
bureaucracy; clinical trials; drug development; regulation; INNOVATION; IMPACT; COST;
D O I
10.1111/bcp.14843
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:4552 / 4559
页数:8
相关论文
共 50 条